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Abstract 
Purpose: To determine the frequencies of important allelic variants and their haplotype frequencies of 
the gene among Jordanian population and to compare findings with those reported for other ethnic 
groups.  
Methods: Genotyping of ABCB1 (C1236T, G2677T/A and C3435T) was carried out on unrelated 
healthy Jordanian subjects. Different allelic variants were determined using polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP). The haplotype frequencies of these three SNPs 
were analyzed and compared them with those of other reported populations. Haplotype frequencies 
were calculated using Golden Helix Tree software and Linkage disequilibrium was represented by D”.   
Results: ABCB1 C3435T allele frequencies for C allele and T allele were 0.57 and 0.43, respectively. 
For ABCB1 G2677T/A the allele frequencies for G allele, T allele, and A allele were 0.65, 0.32 and 0.0, 
respectively. As for ABCB C1236T, its allele frequencies were 0.65 for C allele and 0.35 for T allele. 
C1236T, G2677T/A, and C3435T SNPs were expected to be structured in 8 different haplotypes with G-
C-C (37.6.0 %), T-T-T (18.6 %), G-C-T (14.3 %) and T-T-C (12 %) that were most prominent. The 
haplotype frequency distribution of our study group was found to be significantly different from those of 
Chinese, Indian, Japanese, African and Caucasian (p < 0.0001) and resemble Ashkenazi Jewish and 
Slovenian populations (p > 0.05). 
Conclusion: In addition to earlier studies, the findings of the current study provide evidence that 
suggest the use of genetic polymorphisms of ABCB1 SNPs as markers for ethnicity and ancestral 
origin. The analysis of haplotype and genotype can be useful in identifying the relation between ABCB1 
polymorphism, disease susceptibility and drug disposition.  
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P-glycoprotein (P-gp), and the product of the 
multidrug resistance (MDR1) gene (recently 
renamed ABCB1) plays an important role in the 
bioavailability of a wide variety of drugs and are 
involved in drug-drug interaction in humans [1].  
ABCB1 is highly polymorphic and a number of 
mutations have been documented in various 
ethnic populations [2]. Recently, genetic 
variations of ABCB1 gene have been studied 
very extensively, and over 50 single nucleotide 
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polymorphisms (SNPs) have been reported [1,3]. 
The allelic frequency of ABCB1 SNPs varies 
widely among different ethnic groups [2,4]. 
Among many variants, C3435T (rs1045642) in 
exon 26 (Ile1145Ile); G2677T/A (rs2032582) in 
exon 21 (Ala893Ser/Thr) and C1236T 
(rs1128503) in exon 12 (Gly412Gly) are more 
frequent than other SNPs [5] and have been 
shown to affect the expression and function of P-
gp [6-8]. These three SNPs have been the focus 
of many pharmacokinetic and disease 
association studies with controversial results [9].  
The variant alleles of the three most common 
coding SNPs, at nucleotides 1236, 2677 and 
3435 are in high Linkage disequilibrium as has 
been commonly found in multiple studies [4,9], 
and most haplotype analyse were carried out 
using these three SNPs. Kim et al named the 
haplotype 1236C, 2677G, 3435C as ABCB1*1, 
and the mutant alleles haplotype 1236T, 2677T, 
3435T, was named as ABCB1*2 [8]. 
 
Haplotype analysis, in addition to the customary 
analysis of SNPs, may play an important role in 
the identification of genetic variations between 
ethnic groups. In addition, the functional effects 
of P-gp activity may also be related to haplotypes 
in the ABCB1 gene. The frequencies of the 
important allelic variants in ABCB1 genes have 
been extensively studied in many ethnic groups. 
In the present study, we report the allele 
frequencies of ABCB1 C1236T, G2677T/A and 
C3435T SNPs and their haplotype in a 
sufficiently large sample of apparently healthy 
unrelated Jordanian population. To our 
knowledge, it is the first haplotype frequency 
study of the Jordanian population reported to 
date. 
 
While native Jordanians are mostly descended 
from people of villagers and Bedouin descent 
originating in the Arabian Peninsula [10], 
ethnically, the Jordanians represent a mixed 
stock. Most of the population is Arab 
(approximately 98 %) while 1 % of the population 
is Armenian, and another 1 % is Circassian. 
There are also small Kurd, Druze, and Chechen 






Three hundred and thirty nine (339) apparently 
healthy unrelated Jordanian subjects were 
included in this study after detailed explanation of 
the purpose of the study followed by obtaining 
written informed consent for genetic analysis 
from all of them. The participants had an average 
age of 46.1 ± 15 years and majority of them were 
men (n = 235, 69 %). The study was approved 
by local Research Ethics Committees of the 
Jordan University Hospital (approval reference 
number M/C/A/111/1519, TH/F/3/1/1945 and 
TH/F/3/1/2046), the WMA declaration of Helsinki 
was followed [12].   
 
From each subject, 1 ml of blood was collected. 
Genomic DNA was isolated from the blood using 
Wizard Genomic® (DNA purification kit) 
(Promega Corporation, USA). The isolated DNA 
samples were prepared for genotyping. 
 
Genotype and haplotype analysis 
 
Polymerase chain reaction (PCR) and restriction 
fragment length polymorphism (RFLP) were used 
to identify different SNPs of ABCB1 (C1236T, 
G2677T/A and C3435T). Primers utilized, PCR 
annealing conditions and restriction enzymes are 
summarized in Table 1. 
 
The findings of PCR-RFLP were validated as 
follows:   
 
Table 1: Primer sequences in different SNPs and restriction enzymes used 
 










Reverse:  ggcacctatagcctgcaaaaca 












*PCR products were digested with a restriction enzyme that could distinguish between genotypes and was 
chosen using the website http://tools.neb.com/NEBcutter2/index.php 
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(1) PCR is sensitive to reagents contaminated 
with foreign DNA. A negative control contained 
all PCR components except the DNA template 
was run simultaneously to rule out contaminated 
reagents;  
 
(2) Around 15 % of all samples were repeated to 
confirm findings of the PCR-RFLP;  
 
(3) The PCR-RFLP results of 10 % of samples 
were confirmed for by direct DNA sequencing 
using BigDye Terminator Cycle Sequencing on 





Allele and genotype frequencies for different 
alleles were estimated from the results of the 
above PCR-RFLP test. This estimation was 
carried out as earlier reported [13]. Genotype 
and allele frequency were matched to 
expectation by Hardy-Weinberg Equilibrium; 
differences in allele frequencies between 
Jordanians and other ethnic populations were 
assessed using Chi square test. Haplotype was 
analyzed using Helix Tree Genetics Analysis 
Software, Golden Helix Inc. P < 0.05 was 
considered statistically significant for population 
comparisons.  
 
Linkage disequilibrium was calculated using 
equation [14] and quantified by `D’` and rHo 
square (R2) values, also Linkage disequilibrium 




ABCB1 SNPs frequencies 
 
The frequencies of ABCB1 C1236T, G2677T/A 
and C3435T genotype for the 339 subjects are 
summarized in Table 2. Using Hardy-Weinberg 
equilibrium (H-W) there was no significant 
difference between the findings of the current 
study and H-W expectation (p > 0.05, Chi-
Square) (Table 2). Not all samples were 
successfully analyzed for the three SNPs 
because either we ran out of sample (n = 6), 
failure of DNA extraction (n = 1), or failure of 




The most frequent haplotypes are listed in Table 
3. Linkage disequilibrium was described by D’; 
the standardized, pair wise Linkage-
disequilibrium value D’ was calculated for each 
pair of markers. In the current study, loci 2677 
and 3435 show relatively strong Linkage 
disequilibrium (Lewontin's coefficient [D'] = 
0.765; r2 = 0.426), However, 1236-2677 and 
1236-3435 show weak Linkage disequilibrium 
([D'] = 0.303; r2 = 0.087 and [D'] = 0.319; r2 = 
0.091 respectively). Table 4 shows T-allele 
frequencies among different ethnicities while the 
haplotype frequencies among different ethnicities 
are listed in Table 5. 
 
Table 2: The observed and expected genotype distribution of the tested variants among the Jordanian subjects 
according to Hardy-Weinberg equilibrium 
 




















































































Total number of subjects was 339. Numbers of genotypes do not add up to 339 because: ran out of sample, 
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Table 3: Haplotype frequencies among Jordanians 
 
 Haplotype * EM Probability CHM Prob 
CGC 0.376 0.276 
TTT 0.186 0.11 
CGT 0.143 0.16 
TTC 0.12 0.11 
TGT 0.06 0.10 
TGC 0.06 0.11 
CTT 0.03 0.06 
CTC 0.018 0.08 
Haplotypes order: C3435T-G2677T/A-C1236T; CHM: Composite Haplotype Method; M: Expectation 
Maximization 
 
Table 4: Comparison of the T-allele frequencies of ABCB1 reported from different ethnic populations 
 
Population N 3435 (T) 2677 (T/A) 1236 (T) References 
      
 Jordanian 339 
 

























































































Brazilian ( white) 






























Table 5:  Comparison of haplotype frequencies of ABCB1 reported for different ethnic populations 
 






P- value* References  





























Saudi Arabian  189 48.8 35.5 15.7 < 0.00001 [21] 
Moroccan 100 53 21 26 0.034 [22] 
African American 99 43.6 8.7 47.7 0.036 [23] 





























Ashkenazi Jewish 101 31.7 23.6 44.7 0.57 [25] 
P-values were calculated using: http://www.danielsoper.com/statcalc3/calc.aspx?id=58 
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Several lines of evidence suggest a role for the 
multidrug resistance gene ABCB1/MDR1) to 
disease susceptibility, such as Crohns’ disease 
and cancer [30]. MDR1 is highly expressed in 
drug-resistant cancer cells. Several 
chemotherapeutic agents are affected by MDR1 
genetic polymorphism mainly platinum-based 
chemotherapy response in lung cancer [30]. The 
need to study these different polymorphisms and 
haplotypes has been necessary to evaluate the 
inter-individual variation in disease progression, 
response and treatment especially 
chemotherapeutic agents.  
 
ABCB1 is a highly polymorphic gene, and three 
SNPs that were extensively studied in healthy 
populations as well as in different clinical 
conditions [2,7,30] were investigated in this 
research. The frequencies of ABCB1 allelic 
variants differ widely among different ethnic 
groups [4,8]. 
 
The frequency of the ABCB1 C1236T, G2677T/A 
and C3435T mutant alleles among the Jordanian 
population was 35 %, 32 % and 43 % 
respectively, which is in the range comparable 
with other Caucasians; Americans, German and 
Turkish  populations. On the other hand, the 
frequencies among Jordanians are quite different 
from those reported for Japanese, Chinese 
African American, and Moroccan. Table 4 is a 
comparison between the Jordanian population 
SNPs frequencies from the current study and 
other ethnic populations. 
  
Since the frequency of the polymorphism at 3435 
varies according to ethnicity, it is no surprise that 
the haplotype which carries this SNP shows a 
similar pattern. It is clear that people of African 
origin carry predominantly the wild-type (CGC) 
allele and not the haplotype allele (TTT) [6,23]. In 
Caucasian people, the frequency of CGC and 
TTT alleles is approximately the same [6,23,26]. 
It is interesting that the TTT haplotype is the 
predominant genotype among Asian and Indian 
populations. Table 5 summarizes the haplotype 
distribution of ABCB1 among healthy individuals 
in different races. 
 
Regarding haplotype frequencies among 
Jordanian population, 8 different haplotypes 
appeared in our analysis, the most frequent 
haplotypes were CGC (37.6 %), TTT (18.6 %), 
CGT (14.3 %), TTC (12 %) the other haplotypes 
had frequencies less than 6 % (Table 3). These 
four most frequent haplotypes among Jordanian 
population were also reported to be the four most 
frequent haplotypes among Turkish, Saudi 
Arabia and Jewish populations [21,25,27]. The 
Wild type CGC is the predominant haplotype 
among Jordanian as is the case among other 
Caucasian population [4], but not among Asian, 
Japanese and African populations [19,23,28], in 
which TTT is the predominant haplotype.  
 
When considering the two haplotypes CGC and 
TTT, the reported literature reveals that 
Slovenian and Jewish Populations were the 
closest to the Jordanians [25,27]. These three 
populations had CGC as the most frequent 
haplotype followed by TTT, then by CGT (Table 
5). A new study that has been published among 
Saudi Arabian population regarding haplotype 
frequencies [21], revealed that CGC and TTT are 
the predominant haplotypes with higher 
frequencies compared to Caucasian and 
Jordanian in the present study (Table 5). 
However, the most frequent haplotypes in Saudi 
Arabian and Moroccan populations are similar to 
our study but significantly with different 
frequencies [21,22]. 
 
Linkage disequilibrium has been reported 
between the most common polymorphisms found 
in ABCB1 at positions C1236T, G2677T/A, and 
C3435T [4,8,27]. Of the synonymous SNPs, two 
(C1236T and C3435T) were linked to a non-
synonymous SNP (G2677T/A, Ala893Ser) and 
occurred in 62 % of the European Americans, but 
in only 13 % of the African Americans tested [8].  
Additionally, previous research reported 
statistically significant Linkage disequilibrium 
between all C1236T, G2677T/A, and C3435T 
SNPs [4,27]; However, our results indicated that 
only loci 2677 and 3435 showed relatively strong 
Linkage disequilibrium (Lewontin's coefficient [D'] 
= 0.76 ; r2 = 0.42), as was also observed [18,27].  
 
Limitation of the study 
 
There are more than 50 known SNPs for MDR1 
gene and most studies only analyzed these three 
SNPs as they are considered the most frequent 
SNPs in most populations and are known to 
influence the activity of P-glycoprotein. Only 3 
SNPs were analyzed for haplotyping in this study 
which may limit the interpretation of the results. 
Furthermore, the SNPs were genotyped by PCR-
RFLP and only 10 % of the samples were 
sequenced to confirm the result when a better 
result may have been obtained if all samples 




The current study has successfully determined 
common allelic variants in ABCB1 among 
Jordanian population, some of which are being 
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reported for the first time among the population. 
The frequencies obtained are comparable to data 
previously reported in other populations of 
Caucasian origin but differ from that observed in 
African and Asian populations. Furthermore, 
haplotype frequencies are different from those 
among African, Asian and other populations, but 
resemble those among Jewish and Slovenian 
population. The findings of the current study, in 
addition to earlier studies, provide evidence to 
suggest the use of genetic polymorphisms of 
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